← Back to Search

Home Rehabilitation for Pulmonary Hypertension

N/A
Recruiting
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Inability to follow daily instructions, including the two home 6-minute walk tests during the initial monitoring period
Pulmonary Hypertension Groups 2-5
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 3 months
Awards & highlights

Summary

This trial aims to see if a home rehabilitation program can help patients with Pulmonary Arterial Hypertension by reducing the strain on the heart during physical activity and enhancing their quality of life. If

Who is the study for?
This trial is for patients with Pulmonary Arterial Hypertension (PAH), a type of high blood pressure affecting the lungs. Participants should be able to perform physical activities as part of a home rehabilitation program aimed at reducing cardiac effort and improving quality of life.
What is being tested?
The study tests if a home-based exercise regimen can help PAH patients by decreasing the heart's workload during activity, measured by beats per minute over distance walked in six minutes, compared to standard care without this program.
What are the potential side effects?
Since the intervention involves exercise, potential side effects may include muscle soreness, fatigue, or shortness of breath. However, these are common reactions to starting a new workout routine and typically subside as one adapts.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I can follow daily instructions and perform two 6-minute walk tests at home.
Select...
I have been diagnosed with a type of pulmonary hypertension that is not caused by left heart disease.
Select...
I cannot walk.
Select...
I need more than 6 liters per minute of oxygen when resting.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean change in cardiac effort
Secondary study objectives
Mean change in six minutes walk distance

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exercise Intervention GroupExperimental Treatment1 Intervention
Group II: Standard of CarePlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~820

Find a Location

Who is running the clinical trial?

United TherapeuticsIndustry Sponsor
110 Previous Clinical Trials
14,476 Total Patients Enrolled
59 Trials studying Pulmonary Arterial Hypertension
8,235 Patients Enrolled for Pulmonary Arterial Hypertension
Mayo ClinicOTHER
3,298 Previous Clinical Trials
3,958,395 Total Patients Enrolled
14 Trials studying Pulmonary Arterial Hypertension
1,688 Patients Enrolled for Pulmonary Arterial Hypertension
University of RochesterLead Sponsor
859 Previous Clinical Trials
538,653 Total Patients Enrolled
1 Trials studying Pulmonary Arterial Hypertension
6 Patients Enrolled for Pulmonary Arterial Hypertension
~33 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top